Pharmaco - Press Releases

Date	Title	Company
27-Dec-2019	BTL Files Patent Infringement Lawsuit Against Allergan and Zimmer Related to Emsculpt	BTL
27-Dec-2019	New Major Order From China	Bactiguard Holding AB (publ)
27-Dec-2019	Zur Rose Group: Purchase price payment for medpex acquisition completed early by earn-out settlement	Zur Rose Group AG
27-Dec-2019	Astellas Strengthens Immuno-oncology Pipeline with Acquisition of Xyphos Biosciences, Inc.	Astellas
26-Dec-2019	OBI Pharma Granted FDA Orphan Drug Designation for the Treatment of Pancreatic Cancer for Its Antibody-Drug Conjugate (ADC) Targeted Cancer Therapy, OBI-999	OBI Pharma, Inc.
24-Dec-2019	Viva Biotech Awarded 'Top 10 Public Companies'	Viva Biotech Holdings
24-Dec-2019	Viva Biotech Awarded 'Top 10 Public Companies'	Viva Biotech Holdings
24-Dec-2019	Viva Biotech Awarded 'Top 10 Public Companies'	Viva Biotech Holdings
23-Dec-2019	Auburn's Harrison School of Pharmacy establishes Center for Opioid Research, Education and Outreach	Auburn University
23-Dec-2019	Elysium Health(TM) Announces $40 Million Series C Financing Led by GISEV Family Office	Elysium Health
23-Dec-2019	Abeona Therapeutics Announces Public Offering of Common Stock and Pre Funded Warrants	Abeona Therapeutics
23-Dec-2019	Nanoform files for GMP certification	Nanoform
23-Dec-2019	Global Consortium, Inc. Year End Update	Global Consortium, Inc.
23-Dec-2019	CTT Pharmaceuticals provides Corporate Update	CTT Pharmaceutical Holdings, Inc.
23-Dec-2019	Patient Power® Fuels Patient Action with Reporting on Blood Cancer Progress Seen at the American Society of Hematology Annual Meeting	Patient Power
23-Dec-2019	Portola Pharmaceuticals to Webcast Corporate Update on January 14, 2020	Portola Pharmaceuticals, Inc.®
23-Dec-2019	U.S. FDA Approves Eisai's DAYVIGO(TM) (lemborexant) for the Treatment of Insomnia in Adult Patients	Eisai Inc.
23-Dec-2019	PrimeRx(TM) announces Immunization Registry Reporting via Direct SMP Integration	Micro Merchant Systems
23-Dec-2019	The pivotal Phase 3 Clinical Trial NefIgArd Part A Fully Recruited	Calliditas Therapeutics
23-Dec-2019	TOWA PHARMACEUTICAL CO., LTD. reaches an agreement with ESTEVE to acquire ESTEVE's generic division, Pensa Investments	ESTEVE PHARMACEUTILICALS